1,3oxathiolan-5-one. water, and extracted with ether; the extract was washed with water, dried with anhydrous sodium sulfate and filtered, and the filtrate was distilled. Compound 2a (48 g, 80%) was obtained; bp 78-80°C (12 torr). 1 H NMR spectrum, δ, ppm (J, Hz); 1.31 (3H, t, 3 J HH = 7.2, OCH 2 CH 3 ); 3.52 (1H, d, 2 J HH = 15.9, AB, SCH 2 ); 3.61 (1H, d, 2 J HH = 15.9, AB, SCH 2 ); 4.24 (2H, q, 3 J HH = 7.2, OCHH 2 CH 3 ); 5.51 (1H, q, 3 J HF = 6.6, CF 3 CH). 19 F NMR spectrum, δ, ppm (J, Hz): -72.80 (3F, d, 3 J HF = 6.6, CF 3 CH). Found, %: Cl 15.33; S 13.39. C 6 H 8 ClF 3 O 2 S. Calculated, %: Cl 14.98; S 13.55.[2-(1-Chloro-2,2,2-trifluoroethyl)thio]thio]propionic Acid Methyl Ester (2b) was obtained as for compound 2a, as a mixture of diastereoisomers (1:1). Yield 72%; bp 80-82°C (12 torr). 1 H NMR spectrum, δ, ppm (J, Hz): 1.54 (3H, d, 3 J HH = 7.3, CH 3 CH) and 1.57 (3H, d, 3 J HH = 7.3, CH 3 CH): 3.75 (1H, q, 3 J HH = 7.3, CHCH 3 ) and 3.78 (1H, q, 3 J HH =7.3, CHCH 3 ); 3.79 (3H, s, OCH 3 ) and 3.793 (3H, s, OCH 3 ); 5.47 (1H, q, 3 J HF = 6.7, CHCF 3 ) and 5.58 (1H, q, 3 J HF = 6.7, CHCF 3 ). 19 F NMR spectrum, δ, ppm (J, Hz): -72.86 (3F, two d, 3 J HF = 6.7, CF 3 CH) and -73.63 (3F, d, 3 J HF = 6.7, CF 3 CH). Found, %: Cl 15.24; S 13.41. C 6 H 8 ClF 3 O 2 S. Calculated, %: Cl 14.98; S 13.55.2-Trifluoromethyl-1,3-oxathiolan-5-one (3a). A mixture of sulfide 2a (25 g, 0.106 mol) and anhydrous zinc chloride (3 g, 22 mmol) was heated for 45 min at a temperature of 160-170°C. The reaction mixture was extracted with boiling hexane (4 × 20 ml) and the crystals that precipitated after cooling were filtered out. Compound 3a (15.6 g, 86%) was obtained; mp 61-62°C (mp 62-63°C [2]). 1 H NMR spectrum, δ, ppm (J, Hz): 3.63 (1H, dq, 2 J HH = 16.2, AB, 5 J HF = 1.2, SCH 2 ); 3.81 (1H, d, 2 J HH = 16.2, AB, SCH 2 ); 5.60 (1H, q, 3 J HF = 5.7, CF 3 CH). 19 F NMR spectrum, δ, ppm (J, Hz): -78.96 (3F, dq, 3 J HF = 5.7, 5 J HF = 1.2, CF 3 CH).4-Methyl-2-trifluoromethyl-1,3-oxathiolan-5-one (3b) was obtained as for compound 3a, as a mixture of E-and Z-stereoisomers in a 2:1 ratio. Yield 81%; bp 68-70°C (15 torr). 1 H NMR spectrum, δ, ppm (J, Hz): E-isomer: 1.69 (3H, d, 3 J HH = 7.2, CHCH 3 ); 4.05 (1H, q, 3 J HH = 7.2, CHCH 3 ); 5.59 (1H, q, 3 J HF = 5.2, CHCF 3 ); Z-isomer: 1.62 (3H, d, 3 J HH = 6.8, CHCH 3 ); 4.06 (1H, q, 3 J HH = 6.8, CHCH 3 ); 5.51 (1H, q, 3
The reaction of N-alkyltrifluoroacetimidoyl chlorides with trialkyl phosphites leads to corresponding imidoylphosphonates CF 3 C[P(O)(OAlk) 2 ]=NCH 2 R. These compounds undergo irreversible 1,3-H shift catalyzed by nitrogenous bases to give phosphorylated imines CF 3 CH[P(O)(OAlk) 2 ]N=CHR. The tendency for prototropism increases with increasing electronegativity of substituents R: CF 3 > CH 2 OMe > H > Me. N-Cyclopentyl analogs of the obtained compounds show no tendency for prototropism. Imidoylphosphonates exist mainly as Z isomers [Z/E~(6310) : 1].Imidoylphosphonates are promising synthetic precursors of biologically important derivatives of a-aminophosphonic acids. As they are the [oxidized] form of a-aminophosphonates, reduction of the C=N bond (conversion PC=N 6 PCHN) is a way of their transformation into a-aminophosphoryl derivarives.Intramolecular proton transfer that simulates biochemical transamination allows this process to be performed in the absence of a foreign reducing agent. In previous communications of this series we showed that 1,3-H transfer is characteristic of benz-[2] and some alkanimidoylphosphonates [1]. In the present ÄÄÄÄÄÄÄÄÄÄÄÄ work we synthesized (N-alkyltrifluoroacetimidoyl)-phosphonates I and considered the effect of substituents in the N-alkyl radical on the 1,3-H transfer. The electron-acceptor and simultaneously fairly chemically inert trifluoromethyl group on the sp 2 -carbon atom of compound I favors proton transfer and thus allows synthesis of phosphorus analogs of trifluoroalanine that act as enzyme inhibitors [1,3].Imidoylphosphonates I were prepared by reaction of trialkyl phosphites with imidoyl chlorides II obtained by chlorination of trifluoroacetamides III (Scheme 1). Scheme 1. ; = o ; = g O R CF 3 N R`7 76 X 2 PCl 3 ; o ; = g O R CF 3 R`7 76 I N (AlkO) 3 P ; CF 3 I g
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.